StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Milestone Pharmaceuticals Inc.
NasdaqGS:MIST
Sector
Industries
Location
Market Cap
USD 134.24 M
Share Price
USD 1.58
Avg Daily Volume
1,056,210
Change (1 day)
0.64%
Change (1 year)
6.04%
Change (YTD)
-33.05%
Milestone Pharmaceuticals Inc. EBITDA for the Trailing 12 Months (TTM) ending December 31, 2024: USD -38.59 M
Milestone Pharmaceuticals Inc. EBITDA is USD -38.59 M for the Trailing 12 Months (TTM) ending December 31, 2024. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Milestone Pharmaceuticals Inc. EBITDA for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -59.08 M, a 37.46% change year over year.
-
Milestone Pharmaceuticals Inc. EBITDA for the Trailing 12 Months (TTM) ending December 31, 2021 was USD -42.98 M, a -15.08% change year over year.
-
Milestone Pharmaceuticals Inc. EBITDA for the Trailing 12 Months (TTM) ending December 31, 2020 was USD -50.61 M, a -12.50% change year over year.
Competitors
Eli Lilly and Company
USD 812.69
LLY
+7.26
0.90%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Medtronic plc
USD 92.94
MDT
+0.62
0.67%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
RELX Plc
USD 52.90
REL.L
-0.74
-1.38%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Eli Lilly and Company
USD 812.69
LLY
+7.26
0.90%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Thermo Fisher Scientific Inc.
USD 478.32
TMO
+3.29
0.69%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Medtronic plc
USD 92.94
MDT
+0.62
0.67%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
RELX Plc
USD 52.90
REL.L
-0.74
-1.38%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%